Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
SNY US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Sanofi American Depositary Receipt
(SNY US)
$48.37
-0.09
0.19%
Ext:
$48.04
-0.33
0.68%
(Market Closed · 00:30:01 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
EDINET Filings
Financials
Charting
Short Interest
Employees
Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
SNY US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Sanofi American Depositary Receipt
(SNY US)
$48.37
-0.09
0.19%
Ext:
$48.04
-0.33
0.68%
(Market Closed · 00:30:01 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
EDINET Filings
Financials
Charting
Short Interest
Employees
Chronological
By Owner
EDINET Filings
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological
By Owner
EDINET Filings
Financials & Metrics
Financials
Charting
Short Interest
Employees
SEC Filings by Owner
SEC Filings by Owner
Select Filings
Insider Ownership
Sanofi
(90)
Expand
Form 4
Statement of changes in beneficial ownership
12 Aug
Form 3
Initial statement of beneficial ownership
12 Aug
Form 4
Statement of changes in beneficial ownership
7 Aug
Form 3
Initial statement of beneficial ownership
4 Aug
Form 3
Initial statement of beneficial ownership
13 Aug 2024
Form 4
Statement of changes in beneficial ownership
14 Sep 2021
Form 3
Initial statement of beneficial ownership
12 Aug 2021
Form 4
Statement of changes in beneficial ownership
2 Aug 2021
Form 3
Initial statement of beneficial ownership
28 Jul 2021
Form 4
Statement of changes in beneficial ownership
29 Jul 2020
Sanofi-Aventis Amerique Du Nord S.N.C.
(4)
Expand
Form 4
Statement of changes in beneficial ownership
14 Oct 2010
Form 3
Initial statement of beneficial ownership
11 Feb 2010
Form 4
Statement of changes in beneficial ownership
11 Feb 2010
Form 3
Initial statement of beneficial ownership
21 Dec 2007
AVENTIS INC
(2)
Expand
Form 4
Statement of changes in beneficial ownership
11 Feb 2010
Form 3
Initial statement of beneficial ownership
11 Feb 2010
River Acquisition Corp.
(2)
Expand
Form 4
Statement of changes in beneficial ownership
11 Feb 2010
Form 3
Initial statement of beneficial ownership
11 Feb 2010
GC Merger Corp.
(2)
Expand
Form 4
Statement of changes in beneficial ownership
8 Apr 2011
Form 3
Initial statement of beneficial ownership
6 Apr 2011
≥5% Ownership
Sanofi
(81)
Expand
SC 13G
Agomab Therapeutics NV
6 May
SC 13G
Innate Pharma SA
29 Apr 2025
SC 13G/A
Innate Pharma SA
29 Apr 2025
SC 13G/A
MeiraGTx Holdings plc
13 Aug 2024
SC 13G
Inhibrx Biosciences, Inc.
31 May 2024
SC 13G
MeiraGTx Holdings plc
6 Nov 2023
SC 13G
Icosavax, Inc.
8 Feb 2022
SC 13D
Translate Bio, Inc.
12 Aug 2021
SC 13G
LAVA Therapeutics NV
31 Mar 2021
SC 13G
Revolution Medicines, Inc.
11 Feb 2021
Amundi
(14)
Expand
SC 13G/A
Sanofi
26 Oct
SC 13G/A
Sanofi
22 Jul
SC 13G/A
Sanofi
10 Apr
SC 13G/A
Sanofi
17 Feb
SC 13G/A
Sanofi
14 Nov 2025
SC 13G/A
Sanofi
13 Aug 2025
SC 13G/A
Sanofi
12 May 2025
SC 13G/A
Sanofi
14 Feb 2025
SC 13G/A
Sanofi
7 Nov 2024
SC 13G/A
Sanofi
14 Feb 2024
TOTAL SA
(10)
Expand
SC 13G
Sanofi
14 Feb 2012
SC 13G/A
Sanofi-Aventis
14 Feb 2011
SC 13G/A
Sanofi-Aventis
12 Feb 2010
SC 13G/A
Sanofi-Aventis
17 Feb 2009
SC 13G/A
Sanofi-Aventis
14 Feb 2008
SC 13G/A
Sanofi-Aventis
14 Feb 2007
SC 13G/A
Sanofi-Aventis
14 Feb 2006
SC 13G/A
Sanofi-Aventis
14 Feb 2005
SC 13G/A
Sanofi Synthelabo Sa
13 Feb 2004
SC 13G
Sanofi Synthelabo Sa
13 Feb 2003
BlackRock Inc.
(9)
Expand
SC 13G/A
Sanofi
6 Feb 2024
SC 13G/A
Sanofi
7 Feb 2023
SC 13G/A
Sanofi
3 Feb 2022
SC 13G/A
Sanofi
1 Feb 2021
SC 13G/A
Sanofi
10 Feb 2020
SC 13G/A
Sanofi
11 Feb 2019
SC 13G/A
Sanofi
8 Feb 2018
SC 13G/A
Sanofi
27 Jan 2017
SC 13G
Sanofi
9 Feb 2016
L OREAL S A
(5)
Expand
SC 13G/A
Sanofi-Aventis
14 Apr 2008
SC 13G/A
Sanofi-Aventis
14 Apr 2008
SC 13G/A
Sanofi-Aventis
13 Feb 2006
SC 13G/A
Sanofi Synthelabo Sa
13 Feb 2004
SC 13G
Sanofi Synthelabo Sa
13 Feb 2003
DODGE & COX
(3)
Expand
SC 13G/A
Sanofi
13 Feb 2024
SC 13G/A
Sanofi
14 Feb 2023
SC 13G
Sanofi
14 Feb 2022
CAPITAL GROUP INTERNATIONAL INC
(3)
Expand
SC 13G/A
Sanofi-Aventis
14 Feb 2005
SC 13G/A
Sanofi Synthelabo Sa
13 Feb 2004
SC 13G
Sanofi Synthelabo Sa
11 Feb 2003
KUWAIT PETROLEUM CORP
(2)
Expand
SC 13G/A
Sanofi-Aventis
13 Sep 2004
SC 13G
Sanofi Synthelabo Sa
23 Aug 2004
BlackRock, Inc.
(1)
Expand
SC 13G/A
Sanofi
23 Apr 2025
Select Filings
Insider Ownership
Sanofi
(90)
Expand
Form 4
Statement of changes in beneficial ownership
12 Aug
Form 3
Initial statement of beneficial ownership
12 Aug
Form 4
Statement of changes in beneficial ownership
7 Aug
Form 3
Initial statement of beneficial ownership
4 Aug
Form 3
Initial statement of beneficial ownership
13 Aug 2024
Form 4
Statement of changes in beneficial ownership
14 Sep 2021
Form 3
Initial statement of beneficial ownership
12 Aug 2021
Form 4
Statement of changes in beneficial ownership
2 Aug 2021
Form 3
Initial statement of beneficial ownership
28 Jul 2021
Form 4
Statement of changes in beneficial ownership
29 Jul 2020
Sanofi-Aventis Amerique Du Nord S.N.C.
(4)
Expand
Form 4
Statement of changes in beneficial ownership
14 Oct 2010
Form 3
Initial statement of beneficial ownership
11 Feb 2010
Form 4
Statement of changes in beneficial ownership
11 Feb 2010
Form 3
Initial statement of beneficial ownership
21 Dec 2007
AVENTIS INC
(2)
Expand
Form 4
Statement of changes in beneficial ownership
11 Feb 2010
Form 3
Initial statement of beneficial ownership
11 Feb 2010
River Acquisition Corp.
(2)
Expand
Form 4
Statement of changes in beneficial ownership
11 Feb 2010
Form 3
Initial statement of beneficial ownership
11 Feb 2010
GC Merger Corp.
(2)
Expand
Form 4
Statement of changes in beneficial ownership
8 Apr 2011
Form 3
Initial statement of beneficial ownership
6 Apr 2011
≥5% Ownership
Sanofi
(81)
Expand
SC 13G
Agomab Therapeutics NV
6 May
SC 13G
Innate Pharma SA
29 Apr 2025
SC 13G/A
Innate Pharma SA
29 Apr 2025
SC 13G/A
MeiraGTx Holdings plc
13 Aug 2024
SC 13G
Inhibrx Biosciences, Inc.
31 May 2024
SC 13G
MeiraGTx Holdings plc
6 Nov 2023
SC 13G
Icosavax, Inc.
8 Feb 2022
SC 13D
Translate Bio, Inc.
12 Aug 2021
SC 13G
LAVA Therapeutics NV
31 Mar 2021
SC 13G
Revolution Medicines, Inc.
11 Feb 2021
Amundi
(14)
Expand
SC 13G/A
Sanofi
26 Oct
SC 13G/A
Sanofi
22 Jul
SC 13G/A
Sanofi
10 Apr
SC 13G/A
Sanofi
17 Feb
SC 13G/A
Sanofi
14 Nov 2025
SC 13G/A
Sanofi
13 Aug 2025
SC 13G/A
Sanofi
12 May 2025
SC 13G/A
Sanofi
14 Feb 2025
SC 13G/A
Sanofi
7 Nov 2024
SC 13G/A
Sanofi
14 Feb 2024
TOTAL SA
(10)
Expand
SC 13G
Sanofi
14 Feb 2012
SC 13G/A
Sanofi-Aventis
14 Feb 2011
SC 13G/A
Sanofi-Aventis
12 Feb 2010
SC 13G/A
Sanofi-Aventis
17 Feb 2009
SC 13G/A
Sanofi-Aventis
14 Feb 2008
SC 13G/A
Sanofi-Aventis
14 Feb 2007
SC 13G/A
Sanofi-Aventis
14 Feb 2006
SC 13G/A
Sanofi-Aventis
14 Feb 2005
SC 13G/A
Sanofi Synthelabo Sa
13 Feb 2004
SC 13G
Sanofi Synthelabo Sa
13 Feb 2003
BlackRock Inc.
(9)
Expand
SC 13G/A
Sanofi
6 Feb 2024
SC 13G/A
Sanofi
7 Feb 2023
SC 13G/A
Sanofi
3 Feb 2022
SC 13G/A
Sanofi
1 Feb 2021
SC 13G/A
Sanofi
10 Feb 2020
SC 13G/A
Sanofi
11 Feb 2019
SC 13G/A
Sanofi
8 Feb 2018
SC 13G/A
Sanofi
27 Jan 2017
SC 13G
Sanofi
9 Feb 2016
L OREAL S A
(5)
Expand
SC 13G/A
Sanofi-Aventis
14 Apr 2008
SC 13G/A
Sanofi-Aventis
14 Apr 2008
SC 13G/A
Sanofi-Aventis
13 Feb 2006
SC 13G/A
Sanofi Synthelabo Sa
13 Feb 2004
SC 13G
Sanofi Synthelabo Sa
13 Feb 2003
DODGE & COX
(3)
Expand
SC 13G/A
Sanofi
13 Feb 2024
SC 13G/A
Sanofi
14 Feb 2023
SC 13G
Sanofi
14 Feb 2022
CAPITAL GROUP INTERNATIONAL INC
(3)
Expand
SC 13G/A
Sanofi-Aventis
14 Feb 2005
SC 13G/A
Sanofi Synthelabo Sa
13 Feb 2004
SC 13G
Sanofi Synthelabo Sa
11 Feb 2003
KUWAIT PETROLEUM CORP
(2)
Expand
SC 13G/A
Sanofi-Aventis
13 Sep 2004
SC 13G
Sanofi Synthelabo Sa
23 Aug 2004
BlackRock, Inc.
(1)
Expand
SC 13G/A
Sanofi
23 Apr 2025
Ask in Filing
Ask in Filing